Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1

HM Chang, R Moudgil, T Scarabelli… - Journal of the American …, 2017 - jacc.org
Modern cancer therapy has successfully cured many cancers and converted a terminal
illness into a chronic disease. Because cancer patients often have coexisting heart …

Cardiotoxicity of anticancer treatments: epidemiology, detection, and management

G Curigliano, D Cardinale, S Dent… - CA: a cancer journal …, 2016 - Wiley Online Library
Answer questions and earn CME/CNE Cancer and heart disease are the leading causes of
morbidity and mortality in the industrialized world. Modern treatment strategies have led to …

Cardiotoxicity of anticancer drugs: Molecular mechanisms and strategies for cardioprotection

MB Morelli, C Bongiovanni, S Da Pra… - Frontiers in …, 2022 - frontiersin.org
Chemotherapy and targeted therapies have significantly improved the prognosis of
oncology patients. However, these antineoplastic treatments may also induce adverse …

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College …

2005 Writing Committee Members, SA Hunt… - Circulation, 2009 - Am Heart Assoc
It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

JP Pignon, H Tribodet, GV Scagliotti… - Journal of clinical …, 2008 - ascopubs.org
Purpose Several recent trials have shown a significant overall survival (OS) benefit from
postoperative cisplatin-based chemotherapy in patients with non–small-cell lung cancer …

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American …

Writing Committee Members, SA Hunt, WT Abraham… - circulation, 2005 - Am Heart Assoc
Heart failure (HF) is a major and growing public health problem in the United States.
Approximately 5 million patients in this country have HF, and over 550 000 patients are …

Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention

A Albini, G Pennesi, F Donatelli… - Journal of the …, 2010 - academic.oup.com
Due to the aging of the populations of developed countries and a common occurrence of risk
factors, it is increasingly probable that a patient may have both cancer and cardiovascular …

How do chemotherapeutic agents damage the ovary?

S Morgan, RA Anderson, C Gourley… - Human reproduction …, 2012 - academic.oup.com
BACKGROUND Chemotherapy treatment in premenopausal women is associated with an
increased risk of premature ovarian failure (POF) but the exact mechanism through which …

Chemotherapy‐induced cardiotoxicity: overview of the roles of oxidative stress

P Angsutararux, S Luanpitpong… - Oxidative medicine and …, 2015 - Wiley Online Library
Chemotherapy‐induced cardiotoxicity is a serious complication that poses a serious threat
to life and limits the clinical use of various chemotherapeutic agents, particularly the …

Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study

MG Kaya, M Ozkan, O Gunebakmaz, H Akkaya… - International journal of …, 2013 - Elsevier
Background We aimed to evaluate the effect of prophylactic nebivolol use on prevention of
antracycline-induced cardiotoxicity in breast cancer patients. Methods In this small …